Free Trial
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free NL Stock Alerts

NL Industries (NL) Financials

NL Industries logo
$5.90 +0.04 (+0.75%)
As of 10:23 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for NL Industries

Annual Income Statements for NL Industries

This table shows NL Industries' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 34 -2.31 67
Consolidated Net Income / (Loss)		 36 0.58 69
Net Income / (Loss) Continuing Operations		 36 0.58 69
Total Pre-Tax Income 		39 -6.42 83
Total Operating Income		 14 14 38
Total Gross Profit		 49 49 41
Total Revenue		 167 161 146
Operating Revenue		 167 161 146
Total Cost of Revenue		 118 112 105
Operating Cost of Revenue		 118 112 105
Total Operating Expenses		 35 35 3.49
Selling, General & Admin Expense		 23 24 24
Other Operating Expenses / (Income)		 12 12 -19
Other Special Charges / (Income)		 -0.09 -0.46 -1.37
Total Other Income / (Expense), net		 26 -21 45
Interest Expense		 0.94 0.75 0.53
Interest & Investment Income		 36 -5.37 37
Other Income / (Expense), net		 -9.22 -14 8.61
Income Tax Expense		 2.79 -7.00 14
Net Income / (Loss) Attributable to Noncontrolling Interest		 2.61 2.89 2.03
Basic Earnings per Share		 $0.69 ($0.05) $1.38
Weighted Average Basic Shares Outstanding		 48.81M 48.83M 48.84M
Diluted Earnings per Share		 $0.69 ($0.05) $1.38
Weighted Average Diluted Shares Outstanding		 48.81M 48.83M 48.84M
Weighted Average Basic & Diluted Shares Outstanding		 48.82M 48.83M 48.85M
Cash Dividends to Common per Share		 $0.63 $0.28 $0.75

Quarterly Income Statements for NL Industries

This table shows NL Industries' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -8.90 -6.06 -6.72 -3.11 -0.07 7.59 6.84 7.84 36 17
Consolidated Net Income / (Loss)		 -8.36 -5.45 -5.94 -2.59 0.67 8.44 7.32 8.45 36 17
Net Income / (Loss) Continuing Operations		 -8.36 -5.45 -5.94 -2.59 0.67 8.44 7.32 8.45 36 17
Total Pre-Tax Income 		-14 -6.23 -4.52 -9.89 -0.30 8.29 8.30 9.76 45 20
Total Operating Income		 3.22 2.44 4.20 1.42 3.68 4.83 1.36 0.79 2.04 34
Total Gross Profit		 12 11 13 10 13 14 9.67 11 9.47 11
Total Revenue		 43 40 41 37 40 43 38 36 34 38
Operating Revenue		 43 40 41 37 40 43 38 36 34 38
Total Cost of Revenue		 31 29 28 26 28 30 28 25 24 27
Operating Cost of Revenue		 31 29 28 26 28 30 28 25 24 27
Total Operating Expenses		 8.72 8.71 8.51 8.85 8.94 8.79 8.31 10 7.43 -23
Selling, General & Admin Expense		 8.72 -2.99 8.51 8.85 9.24 -2.82 8.31 10 8.53 -2.88
Total Other Income / (Expense), net		 -17 -8.67 -8.72 -11 -3.98 3.46 6.95 8.96 43 -13
Interest Expense		 0.25 0.20 0.20 0.20 0.20 0.15 0.15 0.15 0.15 0.09
Interest & Investment Income		 7.50 -4.23 -2.67 -5.83 -3.89 7.02 5.03 8.65 25 -1.02
Other Income / (Expense), net		 -24 -4.25 -5.84 -5.28 0.11 -3.42 2.07 0.46 18 -12
Income Tax Expense		 -5.58 -0.78 1.42 -7.30 -0.97 -0.16 0.99 1.30 8.51 3.26
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.55 0.61 0.78 0.52 0.74 0.86 0.48 0.62 0.36 0.58
Basic Earnings per Share		 ($0.18) ($0.13) ($0.14) ($0.06) $0.00 $0.15 $0.14 $0.16 $0.74 $0.34
Weighted Average Basic Shares Outstanding		 48.82M 48.81M 48.82M 48.82M 48.83M 48.83M 48.83M 48.84M 48.85M 48.84M
Diluted Earnings per Share		 ($0.18) ($0.49) ($0.14) ($0.06) $0.00 $0.15 $0.14 $0.16 $0.74 $0.34
Weighted Average Diluted Shares Outstanding		 48.82M 48.81M 48.82M 48.82M 48.83M 48.83M 48.83M 48.84M 48.85M 48.84M
Weighted Average Basic & Diluted Shares Outstanding		 48.82M 48.82M 48.82M 48.83M 48.83M 48.83M 48.83M 48.85M 48.85M 48.85M

Annual Cash Flow Statements for NL Industries

This table details how cash moves in and out of NL Industries' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -78 44 43
Net Cash From Operating Activities		 27 37 26
Net Cash From Continuing Operating Activities		 27 37 26
Net Income / (Loss) Continuing Operations		 36 0.58 69
Consolidated Net Income / (Loss)		 36 0.58 69
Depreciation Expense		 3.98 3.97 3.69
Non-Cash Adjustments To Reconcile Net Income		 3.15 51 -41
Changes in Operating Assets and Liabilities, net		 -17 -19 -6.53
Net Cash From Investing Activities		 -68 22 59
Net Cash From Continuing Investing Activities		 -68 22 59
Purchase of Property, Plant & Equipment		 -3.70 -1.13 -1.43
Purchase of Investments		 -70 -61 0.00
Sale of Property, Plant & Equipment		 0.00 0.00 5.00
Sale and/or Maturity of Investments		 0.00 82 54
Other Investing Activities, net		 5.78 2.60 1.30
Net Cash From Financing Activities		 -37 -15 -42
Net Cash From Continuing Financing Activities		 -37 -15 -42
Payment of Dividends		 -35 -15 -42
Other Financing Activities, net		 -1.74 0.00 0.00
Cash Interest Paid		 0.03 0.05 0.05
Cash Income Taxes Paid		 1.14 -0.30 0.13

Quarterly Cash Flow Statements for NL Industries

This table details how cash moves in and out of NL Industries' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 -23 -59 -21 10 7.44 47 27 29 -21 7.97
Net Cash From Operating Activities		 -0.89 14 7.28 14 -5.46 22 6.74 16 -5.69 8.98
Net Cash From Continuing Operating Activities		 -0.89 14 7.28 14 -5.46 22 6.74 16 -5.69 8.98
Net Income / (Loss) Continuing Operations		 -8.36 -5.45 -5.94 -2.59 0.67 8.44 7.32 8.45 36 17
Consolidated Net Income / (Loss)		 -8.36 -5.45 -5.94 -2.59 0.67 8.44 7.32 8.45 36 17
Depreciation Expense		 1.01 1.02 1.01 1.00 0.99 0.98 0.93 0.92 0.92 0.93
Non-Cash Adjustments To Reconcile Net Income		 24 17 16 19 11 5.69 1.64 0.73 -39 -4.17
Changes in Operating Assets and Liabilities, net		 -17 2.11 -3.49 -3.56 -18 6.43 -3.14 5.44 -3.93 -4.89
Net Cash From Investing Activities		 1.24 -69 -24 0.65 17 29 24 18 13 3.36
Net Cash From Continuing Investing Activities		 1.24 -69 -24 0.65 17 29 24 18 13 3.36
Purchase of Property, Plant & Equipment		 -0.79 -0.69 -0.27 -0.21 -0.09 -0.57 -0.31 -0.43 -0.46 -0.24
Other Investing Activities, net		 2.03 1.50 1.00 - 0.20 1.40 0.80 0.60 1.30 -1.40
Net Cash From Financing Activities		 -24 -3.79 -3.81 -3.81 -3.81 -3.81 -4.37 -4.38 -29 -4.38
Net Cash From Continuing Financing Activities		 -24 -3.79 -3.81 -3.81 -3.81 -3.81 -4.37 -4.38 -29 -4.38
Payment of Dividends		 -24 -3.81 -3.81 -3.81 -3.81 -3.81 -4.37 -4.38 -29 -4.38
Cash Interest Paid		 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Cash Income Taxes Paid		 0.12 0.86 0.17 -0.74 0.10 0.17 -0.13 0.13 0.02 0.11

Annual Balance Sheets for NL Industries

This table presents NL Industries' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets		 610 577 578
Total Current Assets		 194 218 238
Cash & Equivalents		 69 112 163
Restricted Cash		 2.86 2.92 21
Short-Term Investments		 70 53 0.00
Accounts Receivable		 19 18 24
Inventories, net		 31 31 28
Prepaid Expenses		 2.28 2.24 2.15
Plant, Property, & Equipment, net		 29 26 24
Plant, Property & Equipment, gross		 103 104 105
Accumulated Depreciation		 75 78 81
Total Noncurrent Assets		 387 333 316
Long-Term Investments		 319 266 278
Noncurrent Note & Lease Receivables		 13 11 9.30
Goodwill		 27 27 27
Other Noncurrent Operating Assets		 2.52 2.06 1.03
Other Noncurrent Nonoperating Assets		 26 27 0.49
Total Liabilities & Shareholders' Equity		 610 577 578
Total Liabilities		 207 185 162
Total Current Liabilities		 32 30 91
Accounts Payable		 3.54 3.15 3.76
Accrued Expenses		 16 15 70
Other Current Liabilities		 12 12 17
Total Noncurrent Liabilities		 175 154 71
Long-Term Debt		 0.50 0.50 0.50
Asset Retirement Reserve & Litigation Obligation		 117 106 11
Noncurrent Deferred & Payable Income Tax Liabilities		 50 42 53
Noncurrent Employee Benefit Liabilities		 3.01 1.57 0.08
Other Noncurrent Operating Liabilities		 4.28 5.07 6.18
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 403 392 416
Total Preferred & Common Equity		 382 370 397
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 382 370 397
Common Stock		 305 305 305
Retained Earnings		 300 284 315
Accumulated Other Comprehensive Income / (Loss)		 -223 -220 -223
Noncontrolling Interest		 21 22 19

Quarterly Balance Sheets for NL Industries

This table presents NL Industries' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 583 594 586 570 569 580 586
Total Current Assets		 186 199 208 206 218 227 226
Cash & Equivalents		 128 48 59 66 138 167 146
Restricted Cash		 2.83 2.87 2.91 2.92 2.92 2.90 30
Short-Term Investments		 - 96 96 80 30 12 0.00
Accounts Receivable		 19 20 16 21 18 16 15
Inventories, net		 33 30 34 34 28 27 28
Prepaid Expenses		 2.68 2.10 1.77 2.19 1.95 1.88 7.29
Plant, Property, & Equipment, net		 29 28 27 26 25 25 24
Plant, Property & Equipment, gross		 103 103 104 104 104 104 105
Accumulated Depreciation		 74 75 76 77 79 79 80
Total Noncurrent Assets		 368 367 351 338 325 328 336
Long-Term Investments		 298 299 284 271 258 259 300
Noncurrent Note & Lease Receivables		 - - - - 9.80 9.20 7.90
Goodwill		 27 27 27 27 27 27 27
Other Noncurrent Operating Assets		 17 15 14 14 3.50 5.72 0.70
Other Noncurrent Nonoperating Assets		 25 26 26 26 27 27 0.53
Total Liabilities & Shareholders' Equity		 583 594 586 570 569 580 586
Total Liabilities		 200 203 198 185 179 185 181
Total Current Liabilities		 32 27 29 30 25 30 34
Accounts Payable		 5.17 3.93 5.22 3.99 3.07 3.79 3.29
Accrued Expenses		 14 10 12 14 8.98 13 13
Other Current Liabilities		 12 13 13 13 13 13 17
Total Noncurrent Liabilities		 168 176 168 155 154 155 147
Long-Term Debt		 - - - - 0.50 0.50 0.50
Asset Retirement Reserve & Litigation Obligation		 117 117 117 105 106 106 89
Noncurrent Deferred & Payable Income Tax Liabilities		 45 51 44 43 41 43 52
Noncurrent Employee Benefit Liabilities		 2.23 3.06 2.75 2.11 1.58 1.25 0.62
Other Noncurrent Operating Liabilities		 3.20 4.21 4.18 3.98 5.05 5.07 5.08
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 384 391 389 386 390 395 405
Total Preferred & Common Equity		 363 370 368 364 368 373 386
Preferred Stock		 - - - - 0.00 0.00 0.00
Total Common Equity		 363 370 368 364 368 373 386
Common Stock		 305 304 305 305 305 305 305
Retained Earnings		 310 290 284 280 287 291 302
Accumulated Other Comprehensive Income / (Loss)		 -252 -224 -221 -221 -224 -223 -222
Noncontrolling Interest		 20 21 21 21 22 22 19

Annual Metrics And Ratios for NL Industries

This table displays calculated financial ratios and metrics derived from NL Industries' official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 18.28% -3.17% -9.51%
EBITDA Growth		 -71.60% -56.80% 1,268.37%
EBIT Growth		 -82.68% -106.78% 15,291.83%
NOPAT Growth		 38.64% -22.47% 218.35%
Net Income Growth		 -31.68% -98.40% 11,800.52%
EPS Growth		 -34.29% -107.25% 2,860.00%
Operating Cash Flow Growth		 52.94% 37.40% -30.89%
Free Cash Flow Firm Growth		 -17.91% -174.88% 288.92%
Invested Capital Growth		 6.77% 17.99% 32.28%
Revenue Q/Q Growth		 3.67% 2.02% -3.15%
EBITDA Q/Q Growth		 -52.58% 657.64% 66.40%
EBIT Q/Q Growth		 -67.68% 91.32% 75.99%
NOPAT Q/Q Growth		 10.77% 20.36% 310.69%
Net Income Q/Q Growth		 -36.31% 104.37% 14.32%
EPS Q/Q Growth		 -53.69% 92.75% 15.97%
Operating Cash Flow Q/Q Growth		 34.13% 24.74% -32.93%
Free Cash Flow Firm Q/Q Growth		 1,635.96% -101.37% -47.24%
Invested Capital Q/Q Growth		 -17.43% -13.52% 34.47%
Profitability Metrics		 - - -
Gross Margin		 29.30% 30.52% 28.34%
EBITDA Margin		 5.10% 2.27% 34.38%
Operating Margin		 8.24% 8.76% 25.95%
EBIT Margin		 2.71% -0.19% 31.85%
Profit (Net Income) Margin		 21.89% 0.36% 47.46%
Tax Burden Percent		 92.90% -9.07% 83.13%
Interest Burden Percent		 869.70% 2,097.71% 179.23%
Effective Tax Rate		 7.10% 0.00% 16.87%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00%
Return on Equity (ROE)		 9.26% 0.15% 17.15%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.75% -0.05% 8.05%
Return on Assets (ROA)		 6.05% 0.10% 11.99%
Return on Common Equity (ROCE)		 8.75% 0.14% 16.28%
Return on Equity Simple (ROE_SIMPLE)		 9.54% 0.16% 17.45%
Net Operating Profit after Tax (NOPAT)		 13 9.89 31
NOPAT Margin		 7.66% 6.13% 21.57%
Net Nonoperating Expense Percent (NNEP)		 4.94% -1.97% 8.20%
Return On Investment Capital (ROIC_SIMPLE)		 3.16% 2.52% 7.56%
Cost of Revenue to Revenue		 70.70% 69.48% 71.66%
SG&A Expenses to Revenue		 14.03% 14.75% 16.68%
R&D to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 21.05% 21.76% 2.39%
Earnings before Interest and Taxes (EBIT)		 4.51 -0.31 46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 8.49 3.67 50
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.74 0.66 0.96
Price to Tangible Book Value (P/TBV)		 0.80 0.71 1.03
Price to Revenue (P/Rev)		 1.70 1.52 2.60
Price to Earnings (P/E)		 8.37 0.00 5.65
Dividend Yield		 10.86% 5.58% 9.65%
Earnings Yield		 11.95% 0.00% 17.71%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00
Financial Leverage		 -1.22 -1.19 -1.14
Leverage Ratio		 1.53 1.49 1.43
Compound Leverage Factor		 13.32 31.33 2.56
Debt to Total Capital		 0.12% 0.13% 0.12%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.12% 0.13% 0.12%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 5.11% 5.60% 4.56%
Common Equity to Total Capital		 94.77% 94.28% 95.32%
Debt to EBITDA		 0.06 0.14 0.01
Net Debt to EBITDA		 -54.18 -118.04 -9.20
Long-Term Debt to EBITDA		 0.06 0.14 0.01
Debt to NOPAT		 0.04 0.05 0.02
Net Debt to NOPAT		 -36.06 -43.77 -14.66
Long-Term Debt to NOPAT		 0.04 0.05 0.02
Altman Z-Score		 2.13 2.15 2.99
Noncontrolling Interest Sharing Ratio		 5.47% 5.36% 5.07%
Liquidity Ratios		 - - -
Current Ratio		 6.05 7.17 2.61
Quick Ratio		 4.92 5.99 2.05
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 6.73 -5.04 9.52
Operating Cash Flow to CapEx		 728.85% 3,274.60% 0.00%
Free Cash Flow to Firm to Interest Expense		 7.15 -6.76 17.96
Operating Cash Flow to Interest Expense		 28.62 49.60 48.25
Operating Cash Flow Less CapEx to Interest Expense		 24.69 48.09 54.98
Efficiency Ratios		 - - -
Asset Turnover		 0.28 0.27 0.25
Accounts Receivable Turnover		 9.76 8.90 7.04
Inventory Turnover		 4.14 3.62 3.54
Fixed Asset Turnover		 5.76 5.91 5.85
Accounts Payable Turnover		 33.91 33.53 30.29
Days Sales Outstanding (DSO)		 37.38 41.00 51.86
Days Inventory Outstanding (DIO)		 88.23 100.97 103.10
Days Payable Outstanding (DPO)		 10.76 10.89 12.05
Cash Conversion Cycle (CCC)		 114.85 131.08 142.90
Capital & Investment Metrics		 - - -
Invested Capital		 -83 -68 -46
Invested Capital Turnover		 -1.94 -2.14 -2.56
Increase / (Decrease) in Invested Capital		 6.03 15 22
Enterprise Value (EV)		 -156 -166 -63
Market Capitalization		 283 245 380
Book Value per Share		 $7.83 $7.57 $8.13
Tangible Book Value per Share		 $7.27 $7.02 $7.57
Total Capital		 403 392 416
Total Debt		 0.50 0.50 0.50
Total Long-Term Debt		 0.50 0.50 0.50
Net Debt		 -460 -433 -461
Capital Expenditures (CapEx)		 3.70 1.13 -3.57
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 20 20 -37
Debt-free Net Working Capital (DFNWC)		 162 188 147
Net Working Capital (NWC)		 162 188 147
Net Nonoperating Expense (NNE)		 -24 9.31 -38
Net Nonoperating Obligations (NNO)		 -486 -460 -462
Total Depreciation and Amortization (D&A)		 3.98 3.97 3.69
Debt-free, Cash-free Net Working Capital to Revenue		 12.02% 12.54% -25.22%
Debt-free Net Working Capital to Revenue		 97.21% 116.45% 100.65%
Net Working Capital to Revenue		 97.21% 116.45% 100.65%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.69 ($0.05) $1.38
Adjusted Weighted Average Basic Shares Outstanding		 48.81M 48.83M 48.84M
Adjusted Diluted Earnings per Share		 $0.69 ($0.05) $1.38
Adjusted Weighted Average Diluted Shares Outstanding		 48.81M 48.83M 48.84M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 48.82M 48.83M 48.85M
Normalized Net Operating Profit after Tax (NOPAT)		 13 9.57 30
Normalized NOPAT Margin		 7.61% 5.93% 20.79%
Pre Tax Income Margin		 23.56% -3.98% 57.09%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 4.79 -0.41 87.71
NOPAT to Interest Expense		 13.56 13.26 59.41
EBIT Less CapEx to Interest Expense		 0.87 -1.92 94.44
NOPAT Less CapEx to Interest Expense		 9.63 11.74 66.14
Payout Ratios		 - - -
Dividend Payout Ratio		 96.16% 2,616.32% 60.11%
Augmented Payout Ratio		 96.16% 2,616.32% 60.11%

Quarterly Metrics And Ratios for NL Industries

This table displays calculated financial ratios and metrics derived from NL Industries' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 24.04% 17.28% -2.14% -12.14% -5.85% 7.99% -7.73% -1.99% -16.57% -11.00%
EBITDA Growth		 -1,189.79% -109.23% -112.07% -111.83% 123.68% 400.38% 782.42% 175.92% 344.80% 838.48%
EBIT Growth		 -2,479.55% -123.70% -138.14% -116.65% 117.90% 177.96% 307.71% 132.44% 436.44% 1,422.54%
NOPAT Growth		 8.13% 43.39% -13.40% -71.44% 14.46% 188.14% -59.34% -31.09% -35.96% 475.12%
Net Income Growth		 -176.96% -135.58% -130.92% -108.34% 107.99% 254.82% 223.17% 426.24% 5,345.21% 102.74%
EPS Growth		 -185.71% -258.06% -118.92% -109.68% 100.00% 130.61% 200.00% 366.67% 0.00% 126.67%
Operating Cash Flow Growth		 73.37% 93.30% 143.01% 28.41% -512.33% 51.69% -7.34% 13.80% -4.08% -58.30%
Free Cash Flow Firm Growth		 -2,209.73% -2,383.03% -119.73% -870.36% 16.07% -131.79% -2,250.34% 51.95% 247.70% 163.34%
Invested Capital Growth		 14.47% 6.77% 4.21% 11.91% 15.17% 17.99% 18.69% 6.76% -17.31% 32.28%
Revenue Q/Q Growth		 2.85% -6.74% 2.95% -11.02% 10.21% 6.96% -12.03% -5.49% -6.19% 14.11%
EBITDA Q/Q Growth		 -183.43% 96.06% 19.87% -349.14% 266.97% -50.01% 82.04% -50.03% 878.27% 5.47%
EBIT Q/Q Growth		 -191.36% 91.45% 9.01% -134.37% 198.19% -62.77% 142.45% -63.40% 1,523.88% 5.67%
NOPAT Q/Q Growth		 -35.37% -24.13% 72.01% -66.14% 159.04% 91.00% -75.73% -42.63% 140.73% 1,615.38%
Net Income Q/Q Growth		 -126.91% 34.73% -8.89% 56.37% 125.78% 1,164.07% -13.37% 15.56% 330.31% -52.94%
EPS Q/Q Growth		 -129.03% -172.22% 71.43% 57.14% 100.00% 0.00% -6.67% 14.29% 362.50% -54.05%
Operating Cash Flow Q/Q Growth		 -108.39% 1,691.70% -48.74% 87.55% -140.01% 494.31% -68.69% 130.34% -136.60% 257.98%
Free Cash Flow Firm Q/Q Growth		 -886.12% 55.50% 86.43% -1,522.30% 14.36% -22.90% -37.64% 66.84% 363.28% -47.29%
Invested Capital Q/Q Growth		 19.87% -17.43% 3.47% 3.02% 22.83% -13.52% 4.29% -11.21% 2.90% 34.47%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 27.85% 27.90% 30.87% 28.06% 31.27% 31.56% 25.46% 31.11% 28.12% 28.80%
EBITDA Margin		 -47.06% -1.99% -1.55% -7.81% 11.84% 5.53% 11.45% 6.05% 63.11% 58.34%
Operating Margin		 7.50% 6.10% 10.20% 3.88% 9.12% 11.19% 3.57% 2.20% 6.05% 87.71%
EBIT Margin		 -49.41% -4.53% -4.00% -10.54% 9.39% 3.27% 9.01% 3.49% 60.39% 55.92%
Profit (Net Income) Margin		 -19.49% -13.64% -14.43% -7.08% 1.66% 19.56% 19.26% 23.55% 108.04% 44.56%
Tax Burden Percent		 59.98% 87.50% 131.45% 26.20% -224.92% 101.89% 88.10% 86.65% 81.04% 84.01%
Interest Burden Percent		 65.79% 344.36% 274.32% 256.24% -7.84% 587.31% 242.71% 779.15% 220.76% 94.86%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% -1.89% 11.90% 13.35% 18.96% 15.99%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 15.29% 9.26% 2.85% -5.52% -3.46% 0.15% 3.54% 6.35% 15.33% 17.15%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -13.73% -1.25% -1.10% -2.76% 2.57% 0.89% 2.45% 0.94% 15.74% 14.13%
Return on Assets (ROA)		 -5.42% -3.77% -3.96% -1.85% 0.45% 5.32% 5.24% 6.36% 28.16% 11.26%
Return on Common Equity (ROCE)		 14.41% 8.75% 2.69% -5.22% -3.27% 0.14% 3.35% 6.00% 14.54% 16.28%
Return on Equity Simple (ROE_SIMPLE)		 15.76% 0.00% 3.05% -6.08% -3.66% 0.00% 3.76% 6.67% 15.69% 0.00%
Net Operating Profit after Tax (NOPAT)		 2.25 1.71 2.94 0.99 2.58 4.92 1.19 0.69 1.65 28
NOPAT Margin		 5.25% 4.27% 7.14% 2.72% 6.39% 11.40% 3.15% 1.91% 4.90% 73.68%
Net Nonoperating Expense Percent (NNEP)		 -2.35% -1.49% -1.85% -0.74% -0.42% 0.75% 1.32% 1.66% 7.54% -2.43%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.42% - - - 1.25% - - - 6.80%
Cost of Revenue to Revenue		 72.15% 72.10% 69.13% 71.94% 68.73% 68.44% 74.54% 68.89% 71.88% 71.20%
SG&A Expenses to Revenue		 20.34% -7.48% 20.67% 24.18% 22.90% -6.53% 21.89% 28.91% 25.34% -7.49%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 20.34% 21.80% 20.67% 24.18% 22.15% 20.37% 21.89% 28.91% 22.08% -58.91%
Earnings before Interest and Taxes (EBIT)		 -21 -1.81 -1.65 -3.86 3.79 1.41 3.42 1.25 20 21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -20 -0.80 -0.64 -2.86 4.78 2.39 4.35 2.17 21 22
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.90 0.74 0.70 0.65 0.57 0.66 0.90 0.74 0.94 0.96
Price to Tangible Book Value (P/TBV)		 0.97 0.80 0.76 0.71 0.61 0.71 0.97 0.80 1.01 1.03
Price to Revenue (P/Rev)		 2.03 1.70 1.57 1.50 1.31 1.52 2.10 1.76 2.41 2.60
Price to Earnings (P/E)		 5.93 8.37 30.36 0.00 0.00 0.00 29.54 12.46 6.23 5.65
Dividend Yield		 9.30% 10.86% 11.82% 12.80% 6.62% 5.58% 4.26% 5.30% 9.96% 9.65%
Earnings Yield		 16.85% 11.95% 3.29% 0.00% 0.00% 0.00% 3.39% 8.03% 16.05% 17.71%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.20 -1.22 -1.21 -1.20 -1.17 -1.19 -1.19 -1.19 -1.16 -1.14
Leverage Ratio		 1.54 1.53 1.52 1.52 1.50 1.49 1.49 1.49 1.46 1.43
Compound Leverage Factor		 1.02 5.27 4.17 3.88 -0.12 8.77 3.61 11.59 3.23 1.36
Debt to Total Capital		 0.00% 0.12% 0.00% 0.00% 0.00% 0.13% 0.13% 0.13% 0.12% 0.12%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.12% 0.00% 0.00% 0.00% 0.13% 0.13% 0.13% 0.12% 0.12%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 5.31% 5.11% 5.36% 5.43% 5.57% 5.60% 5.62% 5.59% 4.66% 4.56%
Common Equity to Total Capital		 94.69% 94.77% 94.64% 94.57% 94.43% 94.28% 94.25% 94.28% 95.22% 95.32%
Debt to EBITDA		 0.00 0.06 0.00 0.00 0.00 0.14 0.06 0.04 0.02 0.01
Net Debt to EBITDA		 0.00 -54.18 0.00 0.00 0.00 -118.04 -49.49 -32.18 -15.74 -9.20
Long-Term Debt to EBITDA		 0.00 0.06 0.00 0.00 0.00 0.14 0.06 0.04 0.02 0.01
Debt to NOPAT		 0.00 0.04 0.00 0.00 0.00 0.05 0.02 0.05 0.07 0.02
Net Debt to NOPAT		 0.00 -36.06 0.00 0.00 0.00 -43.77 -17.55 -43.26 -61.92 -14.66
Long-Term Debt to NOPAT		 0.00 0.04 0.00 0.00 0.00 0.05 0.02 0.05 0.07 0.02
Altman Z-Score		 2.19 2.09 2.07 2.03 2.03 2.16 2.53 2.29 2.69 2.85
Noncontrolling Interest Sharing Ratio		 5.72% 5.47% 5.50% 5.44% 5.44% 5.36% 5.50% 5.52% 5.11% 5.07%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 5.81 6.05 7.43 7.10 6.87 7.17 8.87 7.69 6.72 2.61
Quick Ratio		 4.60 4.92 6.12 5.79 5.55 5.99 7.56 6.60 4.78 2.05
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -9.70 -4.32 -0.59 -9.51 -8.14 -10 -14 -4.57 12 6.34
Operating Cash Flow to CapEx		 -112.48% 2,066.67% 2,695.56% 6,562.50% -6,351.16% 3,805.12% 2,211.15% 3,655.06% -1,225.22% 3,773.53%
Free Cash Flow to Firm to Interest Expense		 -38.66 -22.03 -2.95 -47.78 -40.31 -68.55 -95.00 -30.87 81.82 70.44
Operating Cash Flow to Interest Expense		 -3.55 72.44 36.57 68.59 -27.04 147.51 46.51 104.96 -38.67 99.79
Operating Cash Flow Less CapEx to Interest Expense		 -6.71 68.93 35.22 67.55 -27.47 143.64 44.41 102.09 -41.83 97.14
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.28 0.28 0.27 0.26 0.27 0.27 0.27 0.27 0.26 0.25
Accounts Receivable Turnover		 9.35 9.76 8.86 9.62 7.93 8.90 8.42 9.99 8.55 7.04
Inventory Turnover		 3.99 4.14 3.99 3.42 3.29 3.62 3.87 3.61 3.43 3.54
Fixed Asset Turnover		 5.58 5.76 5.73 5.68 5.72 5.91 5.96 6.07 5.97 5.85
Accounts Payable Turnover		 23.48 33.91 25.69 19.67 24.31 33.53 31.98 24.47 29.32 30.29
Days Sales Outstanding (DSO)		 39.05 37.38 41.18 37.94 46.06 41.00 43.37 36.55 42.70 51.86
Days Inventory Outstanding (DIO)		 91.42 88.23 91.56 106.86 110.83 100.97 94.21 101.14 106.47 103.10
Days Payable Outstanding (DPO)		 15.55 10.76 14.21 18.55 15.02 10.89 11.41 14.92 12.45 12.05
Cash Conversion Cycle (CCC)		 114.92 114.85 118.53 126.25 141.87 131.08 126.17 122.77 136.73 142.90
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 -71 -83 -80 -78 -60 -68 -65 -72 -70 -46
Invested Capital Turnover		 -2.10 -1.94 -2.02 -1.94 -2.42 -2.14 -2.18 -2.10 -2.31 -2.56
Increase / (Decrease) in Invested Capital		 12 6.03 3.52 11 11 15 15 5.25 -10 22
Enterprise Value (EV)		 -83 -156 -165 -180 -192 -166 -74 -142 -93 -63
Market Capitalization		 325 283 260 240 207 245 332 276 363 380
Book Value per Share		 $7.44 $7.83 $7.59 $7.53 $7.46 $7.57 $7.54 $7.64 $7.90 $8.13
Tangible Book Value per Share		 $6.88 $7.27 $7.03 $6.98 $6.90 $7.02 $6.98 $7.08 $7.35 $7.57
Total Capital		 384 403 391 389 386 392 391 396 405 416
Total Debt		 0.00 0.50 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.50
Total Long-Term Debt		 0.00 0.50 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.50
Net Debt		 -429 -460 -446 -441 -420 -433 -428 -440 -475 -461
Capital Expenditures (CapEx)		 0.79 0.69 0.27 0.21 0.09 0.57 0.31 0.43 0.46 0.24
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 23 20 25 22 27 20 23 16 16 -37
Debt-free Net Working Capital (DFNWC)		 154 162 172 179 176 188 194 198 192 147
Net Working Capital (NWC)		 154 162 172 179 176 188 194 198 192 147
Net Nonoperating Expense (NNE)		 11 7.16 8.88 3.59 1.91 -3.52 -6.12 -7.77 -35 11
Net Nonoperating Obligations (NNO)		 -454 -486 -471 -466 -446 -460 -455 -468 -475 -462
Total Depreciation and Amortization (D&A)		 1.01 1.02 1.01 1.00 0.99 0.98 0.93 0.92 0.92 0.93
Debt-free, Cash-free Net Working Capital to Revenue		 14.44% 12.02% 15.22% 13.63% 17.16% 12.54% 14.46% 9.86% 10.83% -25.22%
Debt-free Net Working Capital to Revenue		 95.84% 97.21% 103.78% 111.48% 111.38% 116.45% 122.51% 125.68% 127.42% 100.65%
Net Working Capital to Revenue		 95.84% 97.21% 103.78% 111.48% 111.38% 116.45% 122.51% 125.68% 127.42% 100.65%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.18) ($0.13) ($0.14) ($0.06) $0.00 $0.15 $0.14 $0.16 $0.74 $0.34
Adjusted Weighted Average Basic Shares Outstanding		 48.82M 48.81M 48.82M 48.82M 48.83M 48.83M 48.83M 48.84M 48.85M 48.84M
Adjusted Diluted Earnings per Share		 ($0.18) ($0.49) $0.82 ($0.06) $0.00 $0.15 $0.14 $0.16 $0.74 $0.34
Adjusted Weighted Average Diluted Shares Outstanding		 48.82M 48.81M 48.81M 48.82M 48.83M 48.83M 48.83M 48.84M 48.85M 48.84M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 48.82M 48.82M 48.82M 48.83M 48.83M 48.83M 48.83M 48.85M 48.85M 48.85M
Normalized Net Operating Profit after Tax (NOPAT)		 2.25 1.71 2.94 0.99 2.36 3.38 1.19 0.69 0.76 28
Normalized NOPAT Margin		 5.25% 4.27% 7.14% 2.72% 5.86% 7.83% 3.15% 1.91% 2.25% 73.68%
Pre Tax Income Margin		 -32.50% -15.59% -10.98% -27.01% -0.74% 19.20% 21.87% 27.18% 133.31% 53.05%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -84.37 -9.23 -8.28 -19.40 18.76 9.66 23.59 8.46 138.31 238.70
NOPAT to Interest Expense		 8.97 8.71 14.76 5.00 12.76 33.71 8.24 4.63 11.22 314.50
EBIT Less CapEx to Interest Expense		 -87.53 -12.74 -9.63 -20.44 18.34 5.79 21.49 5.59 135.15 236.06
NOPAT Less CapEx to Interest Expense		 5.81 5.21 13.41 3.95 12.33 29.83 6.14 1.76 8.07 311.85
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 60.28% 96.16% 309.87% -156.78% -114.34% 2,616.32% 114.16% 65.78% 67.78% 60.11%
Augmented Payout Ratio		 60.28% 96.16% 309.87% -156.78% -114.34% 2,616.32% 114.16% 65.78% 67.78% 60.11%

Financials Breakdown Chart

Key Financial Trends

NL Industries (NYSE: NL) — key takeaways from the latest quarterly and multi-year data

  • Net income to common shareholders rose in Q4 2024, to $16.54 million, up from $7.59 million in Q4 2023. This reflects improved profitability on a quarterly basis.
  • Net income from continuing operations in Q4 2024 was $17.12 million, reversing years of lower or negative results in prior periods. This signals cleaner ongoing profitability for the core business.
  • Diluted earnings per share (EPS) for Q4 2024 reached $0.34, up from $0.15 in Q4 2023. The improving earnings per share supports a more favorable per-share profitability trend.
  • Cash flow from continuing operating activities in Q4 2024 was $8.98 million, with a positive net change in cash of $7.97 million for the quarter, indicating improving cash generation.
  • Revenue was around $38.4 million in Q4 2024, slightly down from Q4 2023’s $43.2 million, but still maintaining a solid quarterly top line.
  • Balance sheet liquidity remains solid, with Long-Term Debt at roughly $0.5 million and cash balances in the mid-hundreds of millions range across recent quarters. This provides a cushion for operating needs.
  • Total assets are substantial (e.g., about $585.7 million in Q3 2024), and total equity sits around $386 million, implying a sizable asset base and equity cushion.
  • Gross margin declined in Q4 2024 to about 28.8% (gross profit of $11.06 million on $38.42 million revenue) from roughly 31.6% in Q4 2023, indicating margin compression.
  • Accumulated Other Comprehensive Income / (Loss) remains deeply negative (approximately -$221 million to -$223 million across recent quarters), which drags on total equity and adds volatility to reported book value.
  • Cash flow shows volatility across quarters, with Q3 2024 posting a meaningful cash outflow and variability in quarterly cash changes, even though Q4 2024 turned positive.
  • Non-operating items (Total Other Income / (Expense), net) swung negative in Q4 2024 (approximately -$13.32 million), highlighting earnings sensitivity to non-core items.
05/14/26 10:23 AM ETAI Generated. May Contain Errors.

NL Industries Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NL Industries' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

NL Industries' net income appears to be on an upward trend, with a most recent value of $69.26 million in 2024, rising from $36.46 million in 2022. The previous period was $582 thousand in 2023. Find out what analysts predict for NL Industries in the coming months.

NL Industries' total operating income in 2024 was $37.88 million, based on the following breakdown:
  • Total Gross Profit: $41.36 million
  • Total Operating Expenses: $3.49 million

Over the last 2 years, NL Industries' total revenue changed from $166.56 million in 2022 to $145.94 million in 2024, a change of -12.4%.

NL Industries' total liabilities were at $162.36 million at the end of 2024, a 12.2% decrease from 2023, and a 21.6% decrease since 2022.

In the past 2 years, NL Industries' cash and equivalents has ranged from $68.87 million in 2022 to $163.15 million in 2024, and is currently $163.15 million as of their latest financial filing in 2024.

Over the last 2 years, NL Industries' book value per share changed from 7.83 in 2022 to 8.13 in 2024, a change of 3.8%.


Related Companies

Financial statements for NYSE:NL last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The US sanctioned itself out of world reserve status…
Russia and Iran are both bypassing the US petrodollar - settling oil trades in alternative currencies while ce...
Golden Portfolio | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Your temporary download link is expiring
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel